Myocyte changes and their left atrial distribution in patients with chronic atrial fibrillation related to mitral valve disease

• Published in: Human pathology 2005-10, Vol.36 (10), p.1080-1089
• Main Authors: Corradi, Domenico, Callegari, Sergio, Benussi, Stefano, Maestri, Roberta, Pastori, Paolo, Nascimbene, Simona, Bosio, Silvia, Dorigo, Enrica, Grassani, Chiara, Rusconi, Raffaella, Vettori, Maria Vittoria, Alinovi, Rossella, Astorri, Ettore, Pappone, Carlo, Alfieri, Ottavio
• Format: Article
• Language: English
• Subjects: Adult; Aged; Apoptosis; Atrial Appendage - pathology; Atrial Appendage - ultrastructure; Atrial fibrillation; Atrial Fibrillation - pathology; Atrial Fibrillation - physiopathology; Biological and medical sciences; Cardiac arrhythmia; Cardiac dysrhythmias; Cardiology. Vascular system; Chronic Disease; Dedifferentiation; Disease; Female; Fibrosis - pathology; Heart; Heart Atria - pathology; Heart Atria - ultrastructure; Heart attacks; Heart Valve Diseases - pathology; Humans; Immunohistochemistry; Investigative techniques, diagnostic techniques (general aspects); Male; Medical sciences; Middle Aged; Mitral Valve - pathology; Mitral Valve - ultrastructure; Models, Anatomic; Myocyte remodeling; Myocytes, Cardiac - pathology; Myocytes, Cardiac - ultrastructure; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques; Pulmonary arteries; Sinuses; Surgery; Ultrastructure
• ISSN: 0046-8177; 1532-8392
• DOI: 10.1016/j.humpath.2005.07.018

It has been found that the pulmonary veins and adjacent left atrial posterior wall (LAPW) are deeply involved in both the initiation and maintenance of atrial fibrillation (AF), and the identification of these high-risk sites has aroused great interest in investigating their histopathologic substrate. We used light and conventional electron microscopy to evaluate the differential myocyte and interstitial changes in LAPW and left atrial appendage (LAA) samples from 28 patients with chronic AF undergoing mitral valve surgery and from 12 autoptic controls. There were always more myocytes with loss of sarcomeres in the LAPW than in the LAA (19.9% ± 7.7% versus 8.2% ± 5.0%; P < .0001), and the LAPW showed more marked immunohistochemical evidence of dedifferentiation, characterized by the reexpression of smooth muscle actin. In pathological left atria, myocyte diameter in the LAPW and LAA was comparable (19.0 ± 1.5 versus 18.5 ± 2.0 μm; not significant) but larger than in the controls (11.9 ± 0.8 and 12.1 ± 1.3 μm, respectively; P < .0001). A terminal deoxynucleotidyltransferase assay did not reveal any myocyte apoptosis. The LAPW also showed more interstitial fibrosis than the LAA (7.49% ± 3.34% versus 2.80% ± 1.35%; P < .0001). Ultrastructural examination confirmed the presence of myocyte myocytolysis in the perinuclear area and showed changes in mitochondrial shape. In conclusion, the LAPW in patients with chronic AF related to mitral valve disease seems to be a particular anatomical site in which major myocyte and interstitial changes are concentrated, whereas the LAA is more protected. This remodeling may increase the heterogeneity of LAPW electrical conduction, thus confirming this location as an elective target for the ablation treatment of AF.